Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Operating Leases: 2022

Historic Operating Leases for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2022 value amounting to $9.0 million.

  • Lexeo Therapeutics' Operating Leases was N/A to $8.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $8.1 million, marking a year-over-year change of. This contributed to the annual value of $9.0 million for FY2022, which is N/A change from last year.
  • As of FY2022, Lexeo Therapeutics' Operating Leases stood at $9.0 million.
  • Lexeo Therapeutics' 5-year Operating Leases high stood at $9.0 million for FY2022, and its period low was $9.0 million during FY2022.
  • In the last 1 years, Lexeo Therapeutics' Operating Leases had a median value of $9.0 million in 2022 and averaged $9.0 million.